SPS
IART icon

Susquehanna Portfolio Strategies’s Integra LifeSciences IART Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
152,371
-17,083
-10% -$239K 0.04% 389
2026
Q1 		$1.6M Buy
169,454
+144,809
+588% +$1.59M 0.02% 547
2025
Q4 		$306K Sell
24,645
-196,911
-89% -$2.62M ﹤0.01% 877
2025
Q3 		$3.17M Buy
+221,556
New +$3.04M 0.05% 403

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Susquehanna Portfolio Strategies's IART Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Integra LifeSciences (IART) stake by 10% in Q2 2026, selling an estimated $239K and leaving 152,371 shares worth $2.74M. The position accounts for 0.04% of the portfolio, ranked #389.

Susquehanna Portfolio Strategies first reported a position in IART in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.17M in Q3 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Susquehanna Portfolio Strategies held 152,371 shares of Integra LifeSciences worth $2.74M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 17,083 Integra LifeSciences shares in Q2 2026, an estimated $239K.
  • Integra LifeSciences made up 0.04% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #389 holding.
  • Susquehanna Portfolio Strategies first reported a position in Integra LifeSciences in Q3 2025 and has held it in 4 quarters since.
  • Susquehanna Portfolio Strategies's Integra LifeSciences position peaked at $3.17M in Q3 2025.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.